Clinical Trial Update: Study Comparing Inhaled Amikacin Versus Placebo to Prevent Ventilator Associated Pneumonia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating inhaled amikacin versus placebo for the prevention of ventilator-associated pneumonia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventilator-associated Pneumonia

Drugs mentioned

• Amikacin (amikacin)

Snippet

Sponsor: University Hospital, Tours | Conditions: Pneumonia, Ventilator-Associated | Phase 3 | Status: COMPLETED